Embecta Corp. Says No Company-Made Syringes Impacted by FDA Safety Communication; Adds That The Safety Notice Issued By The FDA on November 30, 2023, Only Applies To Plastic Syringes Made In China
Portfolio Pulse from Benzinga Newsdesk
Embecta Corp. has announced that none of its syringes are affected by the FDA's safety communication. The FDA's notice, issued on November 30, 2023, specifically pertains to plastic syringes manufactured in China.
December 01, 2023 | 11:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Embecta Corp. has confirmed that its syringes are not included in the FDA's safety communication about Chinese-made plastic syringes.
The clarification from Embecta Corp. that its products are not impacted by the FDA's safety communication is likely to be viewed positively by investors and could alleviate concerns about potential recalls or sales disruptions. This news may lead to a short-term positive impact on the company's stock price as it distances the company from any negative perceptions associated with the FDA's warning.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100